News
CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...
36mon MSN
Another major insurance change coming next year will affect another large swath of Dushay’s patients: In January, BCBS ...
22h
Zacks.com on MSNWill CVS Health's Formulary Move Boost Its Weight Management Program? (Revised)CVS adds Wegovy to its top formularies and bolsters its Weight Management program, aiming to expand access while cutting costs.
Employers, some lawmakers and others have criticized pharmacy benefit managers (PBMs), especially the "big three," for having ...
In the assessment of 12-month price targets, analysts unveil insights for CVS Health, presenting an average target of $79.0, ...
3hon MSNOpinion
In a Kansas City Star guest commentary (6/25/25 page 14A), Jamie Corley, executive director of the nonprofit Prescription ...
View the latest CVS Health Corp. (CVS) stock price, news, historical charts, analyst ratings and financial information from WSJ.
The U.S. Supreme Court declined to review Oklahoma’s PBM law, leaving in place a ruling that found key parts preempted by ERISA and Medicare Part D.
AG Liz Murrill explains why Louisiana filed three major lawsuits against CVS over controversial text messages and business ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results